ASCO 2017: New Drug Shows Durable Efficacy Across Diverse Pediatric and Adult Cancers
Scientists may have developed the first targeted, oral, tumour-type agnostic therapy – a cancer medicine…
Scientists may have developed the first targeted, oral, tumour-type agnostic therapy – a cancer medicine…